Multiple Sclerosis News from Medical News Today

Multiple Sclerosis News

Multiple Sclerosis News

The latest Multiple Sclerosis News articles published daily. Includes news on multiple sclerosis (MS), encephalomyelitis disseminata (ED), myelin and nerve fibers.

Add this Multiple Sclerosis rss news feed to your rss reader:

Latest News

Fit Notes May Help People With MS Stay In Work, UK

28 November 2008

The MS Trust welcomes moves by the government to encourage employers to take a more informed view of the needs of employees with multiple sclerosis. The so called 'fit note', which the government has announced they intend...
[read article]

Health Secretary Praises MS Society At Charity Launch, UK

26 November 2008

The Secretary of State for Health, Alan Johnson MP, praised the work of the MS Society at a reception to launch the charity partnership of the MS Society and British Energy for 2008-09...
[read article]

Study Shows Shocking Cost Of Multiple Sclerosis

25 November 2008

A study of people living with the devastating effects of multiple sclerosis (MS) has shown the true economic cost of living with the incurable, life-long condition. The independent research is one of the...
[read article]

Multiple Sclerosis News Articles Archive - Page 1

25 November 2008

Patients With ALS Do Not Benefit From Growth Hormone

24 November 2008

Woodlands Respite Care Centre Wins Awards - MS Society, UK

20 November 2008

Multiple Sclerosis Trust Stresses The Importance Of Reliable Health Information

18 November 2008

Relapsing-Remitting Multiple Sclerosis - Teva Completes Enrollment In Laquinimod Phase III Clinical Trial

17 November 2008

Environment Causes Increase In Multiple Sclerosis Among Women Only

Nutra Pharma Announces Provision Of RPI-78M Under Compassionate Release To Adrenomyeloneuropathy (AMN) Patients

Sheffield Hallam University (UK) Explores Exercise Intervention For Multiple Sclerosis Sufferers

14 November 2008

Multiple Sclerosis 'barometer' Reveals Wide Variation In Care Across Europe

13 November 2008

Nerve Cells Need Their Armor In The War Against Diseases

Intraspinal Implant Of Mesenchymal Stem Cells May Not Heal The Demyelinated Spinal Cord

Actelion's First-in-class Selective S1P1 Receptor Agonist To Enter Phase II Clinical Development

MS Commissioning Pathway, UK

Interferon Treatment For MS Reduces Lesions In About Half Of Patients

11 November 2008

Only Half Of Patients With Multiple Sclerosis Achieve And Maintain Response To Interferon Treatment

10 November 2008

National Multiple Sclerosis Society New Jersey Metro Chapter Looking For People To Join The Movement

06 November 2008

Predicting Multiple Sclerosis Progression By MRI

Too Much Of A Charge-Switching Enzyme Causes Symptoms Of Multiple Sclerosis And Related Disorders In Mouse Models

MRI Can Predict Multiple Sclerosis Progression

04 November 2008

Source MDx And Brigham And Women's Hospital Partner To Study RNA-Based Biomarkers For Multiple Sclerosis

MS Patients Still Positive For Tysabri Following July Announcement Of PML Cases - PatientsLikeMe Report Indicates

Virtual Reality Helps MS Patients Regain Stability While Walking, Medigait LLC Claims

03 November 2008

MS Services - The Way Forward

31 October 2008

NHS Lagging Behind With IT, Says MS Trust, UK

Interferon Could Be A Key To Preventing Or Treating Multiple Sclerosis

30 October 2008

Obesity, Other Health Problems Delay MS Diagnosis

29 October 2008

3-Substituted Indolones As Novel Therapeutic Compounds For Neurodegenerative Conditions

AbleNet's Impulse™ Bluetooth(R) Technology Access For Computers For People With Significant Physical Limitations

The Right B Cells At The Right Time Fight Nerve Disease

27 October 2008

Dalton Pharma Services And Myelin Repair Foundation Enter Into Chemistry Collaboration

MS Patients Have Significant And Sustained Reduction In Disability And Risk Of Relapse On Alemtuzumab Versus Approved Therapy, Rebif(R)

26 October 2008

BG-12, Biogen Idec's Novel Oral Compound Shown To Significantly Reduced Brain Lesions In Patients With Multiple Sclerosis

25 October 2008

Multiple Sclerosis Disease Activity Reduced After Taking Oral Fumarate

23 October 2008

MS Damage May Be Reversed By Leukemia Drug

Light Shed On Motor Neuron Diseases Like ALS Folowing Gene Discovery

Drug Offers Hope For Multiple Sclerosis Sufferers - Not Only Does It Stop The Disease, Research Indicates It May Restore Lost Function

Statement On University Of Cambridge Miltiple Sclerosis Drug Study

Underlying Cause Of Multiple Sclerosis Targeted By Alemtuzumab

22 October 2008

Commision For Social Care Inspection Proposals Need Action Now - MS Society Cautiously Welcomes Today's Proposals, UK

17 October 2008

Support Multiple Sclerosis By The Book - MS Talent Project Publishes Second Anthology On 19 November, 2008

16 October 2008

Early Treatment With Betaferon At First Sign Of Disease Can Delay Progression To MS

14 October 2008

Pathology Of Multiple Sclerosis Determined By Response To Immune Protein

07 October 2008

Glasgow-based Researchers Develop 'Ground-Breaking' Blood Test

MS Pushed Up The Agenda At Party Conferences

Autoimmune Disease May Be Triggered By Neurotransmitter Defect

05 October 2008

Developments In Technology May Help Diagnose MS In The Future

04 October 2008

BioMS Medical's Phase III U.S. Multiple Sclerosis Trial Receives Positive Safety Review From Data Safety Monitoring Board

01 October 2008

Disease Diagnosis In Just 15 Minutes

30 September 2008

Suspicious Immune Molecule Elevated In MS Patients

29 September 2008

Betaseron(R) To Offer The Thinnest Needle In Multiple Sclerosis

26 September 2008

The Majority Of Children Vaccinated Against Hepatitis B Are Not At Increased Risk Of MS

Five Year Data Confirm That Early Treatment With Betaferon® At First Sign Of Disease Can Delay Progression To MS

25 September 2008

European Medicines Agency Recommends Update Of Product Information OfTysabri And Risk Of Progressive Multifocal Leukoencephalopathy (PML)

24 September 2008

Show Therapeutic Effect Of New Formulation Of Rebif(R) At 16 Weeks In Patients With Multiple Sclerosis

Merck Serono Completes Enrollment In The REFLEX Trial Of Rebif(R) In Patients At Risk Of Developing Multiple Sclerosis

MS Society Welcomes Labour's Commitment On Prescription Charges, UK

23 September 2008

Results From IMPROVE Study Show Therapeutic Effect Of New Formulation Of Rebif(R) At 16 Weeks In Patients With Multiple Sclerosis

ATL/TV1102 Trial Results Presented At World Congress On Treatment And Research In Multiple Sclerosis

Go To News Page:
[1] 2 3 4 5 6 7 8 9 10 11 [Next] [Last Page]

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Back to front page

List of All Medical Articles

Terms and Conditions


News Archive [link] Web Wikipedia Medical Dictionary [link]